Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Conditions: Zika; Zika Virus Infection Interventions: Biological: VLA1601; Biological: CpG 1018 ®; Biological: 3M-052-AF Sponsors: Valneva Austria GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
Conditions: Dengue; Vector Borne Diseases; Arbovirus Infections; Zika; Chikungunya Fever Interventions: Other: Insecticide Coating INESFLY Sponsors: Rocio Cardenas Sanchez; G öteborg University; Instituto Nacional de Salud, Colombia; Instituto Departamental de Salud de Norte de Santander; Universidad Francisco de Paula de Santander Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model
Condition: Zika Virus Infection Interventions: Biological: Cell line and virus; Biological: Infection of human placental culture explants; Biological: Determination of viral load in tissues by qRT-PCR Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2022 Category: Research Source Type: clinical trials
A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults
Condition: Healthy Volunteers Interventions: Biological: Purified Inactivated Zika Virus Vaccine (PIZV); Other: Placebo Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2022 Category: Research Source Type: clinical trials
